Allgens Medical Technology CO., LTD. (688613.SS)
CNY 18.52
(0.76%)
CNY 18.52
(0.76%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 187.23 Million CNY | -8.45% |
| 2022 | 204.52 Million CNY | 1.51% |
| 2021 | 201.48 Million CNY | 30.84% |
| 2020 | 154 Million CNY | 10.21% |
| 2019 | 139.73 Million CNY | 35.82% |
| 2018 | 102.88 Million CNY | 41.34% |
| 2017 | 72.78 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 32.87 Million CNY | -11.63% |
| 2024 Q3 | 32.74 Million CNY | 1.91% |
| 2024 Q1 | 37.2 Million CNY | 7.49% |
| 2023 Q4 | 34.61 Million CNY | -37.47% |
| 2023 Q2 | 58.54 Million CNY | 51.18% |
| 2023 Q1 | 38.72 Million CNY | -33.43% |
| 2023 FY | 187.23 Million CNY | -8.45% |
| 2023 Q3 | 55.36 Million CNY | -5.43% |
| 2022 Q1 | 37.73 Million CNY | -44.91% |
| 2022 Q2 | 48.53 Million CNY | 28.62% |
| 2022 FY | 204.52 Million CNY | 1.51% |
| 2022 Q4 | 58.17 Million CNY | -3.18% |
| 2022 Q3 | 60.08 Million CNY | 23.78% |
| 2021 FY | 201.48 Million CNY | 30.84% |
| 2021 Q2 | 47.02 Million CNY | 49.5% |
| 2021 Q1 | 31.45 Million CNY | -39.23% |
| 2021 Q4 | 68.5 Million CNY | 25.67% |
| 2021 Q3 | 54.5 Million CNY | 15.92% |
| 2020 FY | 154 Million CNY | 10.21% |
| 2020 Q1 | 12.06 Million CNY | -57.97% |
| 2020 Q2 | 21.5 Million CNY | 78.2% |
| 2020 Q3 | 68.67 Million CNY | 219.39% |
| 2020 Q4 | 51.75 Million CNY | -24.64% |
| 2019 FY | 139.73 Million CNY | 35.82% |
| 2019 Q4 | 28.71 Million CNY | 0.0% |
| 2018 FY | 102.88 Million CNY | 41.34% |
| 2017 FY | 72.78 Million CNY | 0.0% |